Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension

被引:2
|
作者
Chen, Xiao [1 ]
Wang, Dong [1 ]
Dong, Rui [1 ]
Yang, Tao [1 ]
Huang, Bo [1 ]
Cao, Yanlong [1 ]
Lu, Jianguo [1 ]
Yin, Jikai [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian, Peoples R China
来源
FRONTIERS IN SURGERY | 2023年 / 10卷
基金
中国国家自然科学基金;
关键词
hypersplenism; prognosis; hepatitis B virus; hepatectomy; hepatocellular carcinoma ( HCC); LIVER-CIRRHOSIS; COMPLICATIONS; SPLENECTOMY; RESECTION; COHORT;
D O I
10.3389/fsurg.2023.1118693
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundAlthough hepatectomy plus splenectomy is not regularly recommended for hepatocellular carcinoma (HCC) with portal hypertension related hypersplenism due to the high risk accompanied with surgical procedures for now. Many researchers still believe that hypersplenism is a controversial adverse prognostic factor for HCC patients. Thus, the primary objective of the study was to determine the effects of hypersplenism on the prognosis of these patients during and after hepatectomy.MethodsA total of 335 patients with HBV-related HCC who underwent surgical resection as primary intervention were included in this study and categorized into three groups. Group A consisted of 226 patients without hypersplenism, Group B included 77 patients with mild hypersplenism, and Group C contained 32 patients with severe hypersplenism. The influence of hypersplenism on the outcome during the perioperative and long-term follow-up periods was analyzed. The independent factors were identified using the Cox proportional hazards regression model.ResultsThe presence of hypersplenism is associated with longer hospital stays, more postoperative blood transfusions, and higher complication rates. The overall survival (OS, P = 0.020) and disease-free survival (DFS, P = 0.005) were significantly decreased in Group B compared to those in Group A. Additionally, the OS (P = 0.014) and DFS (P = 0.005) were reduced in Group C compared to those in Group B. Severe hypersplenism was a significant independent prognostic variable for both OS and DFS.ConclusionSevere hypersplenism prolonged the hospital stay, increased the rate of postoperative blood transfusion, and elevated the incidence of complications. Furthermore, hypersplenism predicted lower overall and disease-free survivals.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Splenectomy Followed by Hepatectomy for Hepatocellular Carcinoma with Hypersplenism and Portal Hypertension Caused by Macroglobulinemia
    Hu, Qingjiang
    Takeishi, Kazuki
    Yamashita, Yo-Ichi
    Ikeda, Tetsuo
    Wang, Huanlin
    Itoh, Shinji
    Harimoto, Norifumi
    Ikegami, Toku
    Yoshizumi, Tomohaku
    Kawanaka, Hirofumi
    Shikabe, Ken
    Maehaka, Yoshihiko
    ANTICANCER RESEARCH, 2015, 35 (07) : 4077 - 4081
  • [2] Outcome of Hepatectomy for Hepatocellular Carcinoma in Elderly Patients With Portal Hypertension
    Mori, Shozo
    Kita, Junji
    Shimizu, Takayuki
    Kato, Masato
    Shimoda, Mitsugi
    Kubota, Keiichi
    INTERNATIONAL SURGERY, 2014, 99 (02) : 153 - 160
  • [3] Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Jong Man Kim
    Choon Hyuck David Kwon
    Jae-Won Joh
    Heejin Yoo
    Kyunga Kim
    Dong Hyun Sinn
    Gyu-Seong Choi
    Joon Hyeok Lee
    Journal of Gastrointestinal Surgery, 2019, 23 : 1559 - 1567
  • [4] Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Kim, Jong Man
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    Yoo, Heejin
    Kim, Kyunga
    Sinn, Dong Hyun
    Choi, Gyu-Seong
    Lee, Joon Hyeok
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (08) : 1559 - 1567
  • [5] MicroRNAome of Splenic Macrophages in Hypersplenism due to Portal Hypertension in Hepatitis B Virus-Related Cirrhosis
    Li, Zongfang
    Zhang, Shu
    Huang, Chen
    Zhang, Wei
    Hu, Yajun
    Wei, Bo
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (11) : 1454 - 1461
  • [6] Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial
    Yuan, Yichuan
    Peng, Hong
    He, Wei
    Zheng, Yun
    Qiu, Jiliang
    Chen, Bin
    Zou, Ruhai
    Wang, Chenwei
    Lau, Wan Yee
    Li, Binkui
    Yuan, Yunfei
    CANCER COMMUNICATIONS, 2024, 44 (11) : 1337 - 1349
  • [7] The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma
    Ke, Lixin
    Shen, Rui
    Fan, Wenzhe
    Hu, Wenjie
    Shen, Shunli
    Li, Shaoqiang
    Kuang, Ming
    Liang, Lijian
    Li, Jiaping
    Peng, Baogang
    Hua, Yunpeng
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [8] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, (03) : 158 - 164
  • [9] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, 10 (03) : 158 - 164
  • [10] Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy
    Wan, Dong-Ling
    Sun, Li-Qi
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (09):